Tag: Urinary Tract Infection
A spine-tingling new frontier
One Sydney scientist likens it to the lunar mission; a potentially great but risky step forward. For some people with spinal cord injury -...
InVivo nears human trials of spine-injury treatment
Spinal cord injury treatment maker InVivo Therapeutics Corp. has successfully wrapped up preliminary primate studies and is now looking to secure funds to go...
Collaboration Between Burnham And HeadNorth
HeadNorth Foundation has pledged $975,000 to Burnham Institute for Medical Research (Burnham) to support cutting-edge stem cell research. The funding, part of HeadNorth's Chronic...
Crackdown urged on ‘rogue’ stem cell clinics
Treatment benefits exaggerated, risks underestimated, researchers warn
Stem cell clinics promising costly cures for everything from Parkinson's disease to spinal cord injury grossly exaggerate the...
Obama policy a lift for stem cell researchers
Stem cell research advocates have waited nearly eight years for the policy change President-elect Barack Obama has signaled he'll make in the early days...
Spinal Cord Repair Researcher Nets $150,000 Award
When they were 15, Tim O'Shea and his friend Ben Harvey were keen rugby players. But a week before his sixteenth birthday Ben was...
PREMIER OPENS WORLD-LEADING SPINAL CORD INJURY CENTRE
VANCOUVER – The world’s largest, most advanced and most comprehensive facility devoted to spinal cord injury research and patient care was opened today by...
3 with local ties inducted
Dr. James S. Krause, Harriet McBryde Johnson and Marc Buoniconti
Three of this year's 19 inductees into the Spinal Cord Injury Hall of Fame have...
SYGNIS Receives Orphan Drug Designation from the European Commission for AX200 in the treatment...
-Second indication for AX200 given Orphan Drug status
SYGNIS Pharma AG, today announced that it has received Orphan Drug designation from the European Commission for...
StemCells, Inc. Announces Four Presentations at Society for Neuroscience Annual Meeting
PALO ALTO, Calif. — StemCells, Inc. (Nasdaq:STEM) announced today that results pertaining to the Company's research programs in retinal degeneration as well as spinal...
